Free Trial

Viking Therapeutics (VKTX) News Today

Viking Therapeutics logo
$51.74 +0.21 (+0.41%)
(As of 11/21/2024 ET)
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Shares Up 0.3% - Here's What Happened
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 0.3% - Here's What Happened
Viking Therapeutics, Inc. stock logo
Royce & Associates LP Invests $844,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Royce & Associates LP acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 13,334 shares of the biotechnology company's stock, v
Brokerages Set Viking Therapeutics, Inc. (NASDAQ:VKTX) PT at $109.80
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 0.5% - Here's What Happened
Viking Therapeutics (NASDAQ:VKTX) Shares Down 0.5% - Here's Why
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Earns Outperform Rating from William Blair
William Blair reaffirmed an "outperform" rating on shares of Viking Therapeutics in a research note on Wednesday.
Viking Therapeutics, Inc. stock logo
JW Asset Management LLC Makes New Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)
JW Asset Management LLC purchased a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 45,000 shares of the biotech
Viking to present data from Phase 2b VOYAGE study in late breaker presentation
Viking Therapeutics reports results from Phase 2b clinical trial of VK2809
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1% - Here's Why
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1% - Here's Why
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.4% - Here's What Happened
Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.4% - Time to Sell?
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Buy" by Brokerages
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) have earned an average rating of "Buy" from the eleven analysts that are covering the firm, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy recommendation and one has given a strong buy r
Viking Therapeutics, Inc. stock logo
LJI Wealth Management LLC Has $1.17 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
LJI Wealth Management LLC lessened its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 39.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 18,400 shares of the biotechnology company's stock after selling 11,800 shares during th
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.9% - Should You Sell?
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 2.9% - What's Next?
Viking Therapeutics, Inc. stock logo
Oppenheimer & Co. Inc. Buys 31,011 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
Oppenheimer & Co. Inc. increased its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 43.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 102,324 shares of the biotechnology company's stock after acquiring an additional
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1% - Should You Sell?
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 1% - Time to Sell?
Viking Therapeutics, Inc. stock logo
Aptus Capital Advisors LLC Boosts Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Aptus Capital Advisors LLC lifted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 34.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,143 shares of the biotechnology company's stoc
Viking Therapeutics, Inc. stock logo
Sigma Planning Corp Takes $957,000 Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Sigma Planning Corp bought a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 15,119 shares of the biotechnology company's stock, valued at approximately $957,000. A
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Shares Down 3.1% - Here's Why
Viking Therapeutics (NASDAQ:VKTX) Shares Down 3.1% - Should You Sell?
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by Chartwell Investment Partners LLC
Chartwell Investment Partners LLC lifted its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 88.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,666 shares of the biotechnology company's stock a
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 5.6% - What's Next?
Viking Therapeutics (NASDAQ:VKTX) Shares Down 5.6% - Here's What Happened
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by Principal Financial Group Inc.
Principal Financial Group Inc. boosted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 29.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 593,528 shares of the biotechnology co
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 2.2% After Insider Selling
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 2.2% on Insider Selling
Is Viking Therapeutics a Buy on the Dip?
Viking Therapeutics, Inc. stock logo
Fiera Capital Corp Makes New $18.44 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Fiera Capital Corp acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 291,318 shares of the biotechnology company's
Viking Therapeutics, Inc. stock logo
Insider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) Director Sells 2,000 Shares of Stock
Viking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) Director Lawson Macartney sold 2,000 shares of the business's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $68.67, for a total transaction of $137,340.00. Following the completion of the sale, the director now owns 47,965 shares of the company's stock, valued at approximately $3,293,756.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 0.8% - What's Next?
Viking Therapeutics (NASDAQ:VKTX) Trading Down 0.8% - Here's What Happened
Viking Therapeutics, Inc. stock logo
Quantum Private Wealth LLC Acquires 7,161 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
Quantum Private Wealth LLC increased its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 84,084 shares of the biotechnology company's stock after
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Shares Up 0.3% - Time to Buy?
Viking Therapeutics (NASDAQ:VKTX) Trading Up 0.3% - Should You Buy?
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by AlphaCentric Advisors LLC
AlphaCentric Advisors LLC decreased its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 78.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,500 shares of the biotechnology company
Is Viking Therepautics a Buy Now?
Viking Therapeutics (VKTX) Gets a Buy from Stifel Nicolaus
Get Viking Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter.

Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Check out the $100 Challenge now

VKTX Media Mentions By Week

VKTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VKTX
News Sentiment

0.49

0.48

Average
Medical
News Sentiment

VKTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VKTX Articles
This Week

25

14

VKTX Articles
Average Week

Get Viking Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VKTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners